What will health look like in 2040?
An interactive video
Twenty years from now, the life sciences and health care industry will be transformed—consumers will own their journey of health, and traditional and nontraditional organizations will work together seamlessly to focus on health and well-being.
2021 global life sciences outlook
Possibility is now reality, sustaining forward momentum
Navigating the pandemic has been an all-encompassing, once-in-a-lifetime challenge. Globally, life sciences companies responded with leadership and are emerging stronger. Explore how life sciences companies responded and areas where they can build resiliency going forward.
Breaking barriers to digitalization in biopharma
The pandemic's impact on R&D and commercial operating models
The COVID-19 pandemic has changed the way biopharma does business, from trials to manufacture to sales. Once things get back to normal, will it be business as usual or will the industry evolve and implement learnings from this period?
2021 global health care outlook
Accelerating industry change
With the COVID-19 pandemic accelerating change across the health care ecosystem, industry leaders are likely to use the momentum to address six pressing issues in 2021: consumers and the human experience, care model innovation, digital transformation and interoperable data, socio-economic shifts, collaboration, future of work and talent.
Overcoming challenges and achieving resilience: The changing role of health care finance leaders to help ensure long-term success
2021 Health care CFO study
The pandemic was a catalyst for change in the health care industry. Explore how health care finance leaders, with their broadening role, are influencing technology investments, rethinking work, and enabling a health equity agenda as ways to position their organizations for success.